Results 171 to 180 of about 91,427 (251)

Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism

The FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Transplanting the fecal microbiota of patients with lung injury into mice causes an increase in LPS in the mice's blood, thereby leading to chronic lung injury in the mice. Meanwhile, oral administration of vancomycin can enhance colonic butyrate metabolism and improve lung injury in mice.
Jianuo Chen, Shanshan Su, Xi Zhang, Fen Xiong, Hong Zheng, Wenli Zhang, Yuying Shen, Pengcheng Lin, Hongchang Gao, Yuping Li   +9 more
wiley   +1 more source

Successful desensitization to liposomal amphotericin B for the treatment of disseminated cryptococcosis in pregnancy: a case report. [PDF]

ASM Case Rep
Ajao SO, Nelson JM, Yassin A, Rosenfeld EB, Brandt JS, Monteleone C, Bhatt PJ, Abdul Azim A.   +7 more
europepmc   +1 more source

Probing 5‐Nitroimidazole‐Triazole Hybrids as Potential Anti‐Kinetoplastid Agents: Synthesis and In Vitro Efficacy

ChemMedChem, Volume 21, Issue 13, 14 July 2026.
A series of 5‐nitroimidazole‐1,2,3‐triazole hybrids was synthesised and evaluated for antitrypanosomatid activity to assess their potential as treatments against leishmaniasis and trypanosomiasis. No notable in vitro activity against Leishmania was detected.
Liandi Ferreira, Gideon D. Badenhorst, Janine Aucamp, Keisuke Suganuma, David D. N’Da   +4 more
wiley   +1 more source

Dosing and safety of amphotericin B deoxycholate in paediatric American cutaneous leishmaniasis in Peru: a case series. [PDF]

BMC Infect Dis
Sanchez-Diaz M, Hernandez R, Verne E, Gallegos J, Jordan B, Lopez J, Lagos EG, Alvarez F, Llanos-Cuentas A.   +8 more
europepmc   +1 more source

AMF-responsive nanobiomagnetite for targeted delivery of amphotericin B against Leishmania amazonensis. [PDF]

Sci Rep
Verdan M, Nico D, Sangenito L, Garcia F, Santos ALS, Abreu F.   +5 more
europepmc   +1 more source

Multidistrict invasive <i>Candida glabrata</i> infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective. [PDF]

Front Med (Lausanne)
Caracciolo M, D'Aleo F, Stagno MF, Papola C, Pellicano S, Nicolò GM, Caracciolo SA, Ripepi A, Pellicano N, Scopelliti C, Principe L, La Scala S.   +11 more
europepmc   +1 more source

Liposomal amphotericin B prophylaxis in paediatrics: a systematic review. [PDF]

J Antimicrob Chemother
Thorley EV, Hatch J, Li M, Mashida SN, Castagnola E, Mesini A, Lehrnbecher T, Groll AH, Warris A, Ferreras-Antolin L.   +9 more
europepmc   +1 more source

High mortality and amphotericin B-related nephrotoxicity in cerebral cryptococcosis in a low-resource neurology referral center: a prospective cohort study. [PDF]

Front Neurol
Lobo Requena JY, Quintero M, Pachano Arenas F, Belloso de Noriega V, Marin-Hamburger Y, Kalokoh S, Visconti-Lopez FJ.   +6 more
europepmc   +1 more source

Synergistic effects of dioscin and amphotericin B against <i>Candida albicans</i>: a promising strategy for antifungal therapy. [PDF]

Front Cell Infect Microbiol
Liu X, Xu F, Zhang Y, Zhong L, Yang L.
europepmc   +1 more source

Synergistic eradication of <i>Candida albicans</i> prosthetic valve endocarditis with liposomal amphotericin B and high-dose caspofungin: a case report. [PDF]

Front Med (Lausanne)
Feng Q, Huang L, Luo H, Peng X, Zhang S.
europepmc   +1 more source